Seife Yohannes

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

C. del Rio, L. Lam, C. Libertin, 2021, The Lancet Respiratory Medicine.

Subcutaneous and mediastinal emphysema, uncommon complications of COVID-19 ARDS: a case series

P. Clark, A. Pratt, Seife Yohannes, 2021, Journal of Emergency and Critical Care Medicine.

Incidence and Impact of Ventilator Associated Multidrug Resistant Pneumonia in Patients with SARS-COV2

Z. Ahmed, A. Pratt, S. Perinkulam Sathyanarayanan, 2022, Critical care research and practice.

Pyomyositis caused by methicillin-resistant Staphylococcus aureus.

M. Ruiz, Christopher G Wladyka, Seife Yohannes, 2005, The New England journal of medicine.

Pediatric sepsis phenotypes for enhanced therapeutics: An application of clustering to electronic health records

J. Chamberlain, I. Koutroulis, R. Freishtat, 2022, Journal of the American College of Emergency Physicians open.

Identification of Pediatric Sepsis Subphenotypes for Enhanced Machine Learning Predictive Performance: A Latent Profile Analysis pdf

Tony Wang, Emilia Apostolova, Tom Velez, 2019, ArXiv.

Incidence of barotrauma in patients with COVID-19 (alpha- and beta-predominant period) requiring mechanical ventilation: Single-center retrospective study

Shan Sivanushanthan, M. Hockstein, Seife Yohannes, 2023, SAGE open medicine.

Impact of an Early Warning System Protocol, for Patients Admitted to the Medical Floors with SARS-COV2 Pneumonia, on ICU Admission

N. Seam, Joel McAlduff, Seife Yohannes, 2023, Clinical medicine insights. Circulatory, respiratory and pulmonary medicine.